Need professional-grade analysis? Visit stockanalysis.com
$10.10B
18.08
24,611
0.72%
Price Chart
Risk-Adjusted Performance
Encompass Health Corp (EHC) Price Performance
Encompass Health Corp (EHC) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at $97.49, up 1.70% from the previous close.
Over the past year, EHC has traded between a low of $93.83 and a high of $126.95. The stock has lost 2.2% over this period. It is currently 23.2% below its 52-week high.
Encompass Health Corp has a market capitalization of $10.10B, with a price-to-earnings ratio of 18.08 and a dividend yield of 0.72%.
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Company Info
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $4.80B
- EBITDA
- $1.38B
- Profit Margin
- 9.54%
- EPS (TTM)
- 5.55
- Book Value
- 24.38
Technical Indicators
- 52 Week High
- $127.76
- 52 Week Low
- $92.48
- 50 Day MA
- $103.64
- 200 Day MA
- $114.43
- Beta
- 0.56
Valuation
- Trailing P/E
- 18.08
- Forward P/E
- 16.86
- Price/Sales
- 1.70
- Price/Book
- 4.09
- Enterprise Value
- $13.83B